Research groups
Colleges
Patrik Rorsman
BM, PhD, FRS, FMedSci
Professor of Diabetic Medicine
Diabetes, Insulin secretion
We study the normal regulation of plasma glucose and how it becomes disrupted in diabetes. Our work focuses on the cells that secrete the plasma glucose-regulating hormones glucagon (that increases plasma glucose) and insulin (that lowers plasma glucose). In diabetes, insulin secretion is reduced and glucagon secretion increased. The aim of our work is to establish why these disturbances develop and if they can be corrected pharmacologically.
Recent publications
-
Incretin hormones, insulin, glucagon and advanced glycation end products in relation to cognitive function in older people with and without diabetes, a population-based study.
Journal article
Dybjer E. et al, (2020), Diabet Med
-
Somatostatin secretion by Na+-dependent Ca2+-induced Ca2+ release in pancreatic delta-cells.
Journal article
Vergari E. et al, (2020), Nat Metab, 2, 32 - 40
-
Loss of ZnT8 function protects against diabetes by enhanced insulin secretion.
Journal article
Dwivedi OP. et al, (2019), Nat Genet
-
Glucose stimulates somatostatin secretion in pancreatic δ-cells by cAMP-dependent intracellular Ca2+ release.
Journal article
Denwood G. et al, (2019), J Gen Physiol, 151, 1094 - 1115
-
Diabetes causes marked inhibition of mitochondrial metabolism in pancreatic β-cells.
Journal article
Haythorne E. et al, (2019), Nat Commun, 10
ORCID
0000-0001-7578-0767